National Health Investors, Inc. (NYSE:NHI) Q1 2020 Earnings Conference Call May 12, 2020 ET Company Participants Dana Hambly - Director of Investor Relations Eric Mendelsohn - President & Chief Executive Officer Kevin Pascoe - Chief Investment Officer John Spaid - Executive Vice President & Chief Financial Officer Conference Call Participants Daniel Bernstein - Capital One Connor Siversky - Berenberg Tayo Okusanya - Mizuho Rich Anderson - SMBC Todd Stender - Wells Fargo Jordan Sadler - KeyBanc Capital Marke ...

Q1 2020 SUPPLEMENTAL HEROES AT WORK NATIONAL HEALTH INVESTORS TABLE OF CONTENTS 1 Q1 2020 National Health Investors | --- | --- | |---------------------------------------------|-------| | COMPANY \n COMPANY INFORMATION & LEADERSHIP | 02 | | PORTFOLIO | | | PORTFOLIO OVERVIEW | 03 | | PORTFOLIO SUMMARY | 04 | | OPERATING PARTNERS | 05 | | EBITDARM LEASE COVERAGE | 06 | | PURCHASE OPTIONS & LEASE MATURITIES | 07 | | INVESTMENTS | | | INVESTMENT RATIONALE | 08 | | RECENT INVESTMENTS | 09 | | CAPITALIZATION | | ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Commission File Number 001-10822 National Health Investors Inc (Exact name of registrant as specified in its charter) | Maryland | | 62-1470956 | | --- | --- | --- | | (State or other jurisdiction of incorporation or | | | | organization) | | (I.R.S. Employer Identification No.) | | 222 Robert Rose Drive | | | | Murfreesboro | Tennessee | 37129 | | (Address of principal executive offices) | | (Zip Code) | (615) 890-9100 (Registrant's te ...

National Health Investors, Inc. (NYSE:NHI) Q4 2019 Earnings Conference Call February 19, 2020 12:00 PM ET Company Participants Dana Hambly - Director, IR Eric Mendelsohn - President and Chief Executive Officer John Spaid - Chief Financial Officer Kevin Pascoe - Chief Investment Officer Conference Call Participants Seth Canetto - Stifel, Nicolaus & Company Daniel Bernstein - Capital One John Kim - BMO Capital Markets Omotayo Okusanya - Mizuho Securities USA Connor Siversky - Berenberg Jordan Sadler - KeyBanc ...

Q4 2019 NATIONAL HEALTH INVESTORS 8, DECO ETH 口コレロ HVE 日 19 E ■ E 口回口。 an Q4 2019 SUPPLE TABLE OF CONTENTS 1 Q4 2019 National Health Investors | --- | --- | |---------------------------------------------|-------| | COMPANY \n COMPANY INFORMATION & LEADERSHIP | 02 | | PORTFOLIO | | | PORTFOLIO OVERVIEW | 03 | | PORTFOLIO SUMMARY | 04 | | OPERATING PARTNERS | 05 | | EBITDARM LEASE COVERAGE | 06 | | PURCHASE OPTIONS & LEASE MATURITIES | 07 | | INVESTMENTS | | | INVESTMENT RATIONALE | 08 | | RECENT INVESTMENTS ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File Number 001-10822 National Health Investors Inc (Exact name of registrant as specified in its charter) | Maryland | 62-1 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | Commission File Number 001-10822 National Health Investors Inc (Exact name of registrant as specified in its charter) | Maryland | | 62-1470956 | | --- | --- | --- | | (State or othe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File Number 001-10822 National Health Investors Inc (Exact name of registrant as specified in its charter) | Maryland | ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [ x ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File Number 001-10822 National Health Investors, Inc. (Exact name of registrant as specified in its charter) Mary ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) [ x ] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [ ] No [ x ] Indicate by check mark whether the registrant (1) ...